S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
ETON · Eton Pharmaceuticals, Inc.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
Eton Pharmaceuticals Inc (ETON)
NASDAQ NMS - GLOBAL MARKET
Pharmaceuticals
$49.24
-0.89
(-1.77%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$49.24
$48.78
$50.93
52-WEEK RANGE
$49.24
$14.27
$66.37
What's happening
- ETON is down 1.77% today, trading at $49.24. — Live quote
- Volume today (16,471) is well below its 3-month average of 559,100. (Finnhub fundamentals)
- Reports earnings on 2026-11-05, 14 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $0.35 actual vs. $0.11 estimated (+226.8%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 2
Buy 7
Hold 1
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (10 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
ETON
+196.81%
vs S&P 500
+184.03%
1-YEAR RETURN
ETON
+172.77%
vs S&P 500
+158.21%
6-MONTH RETURN
ETON
+105.44%
3-MONTH RETURN
ETON
+16.18%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$0.35
Est. $0.11
BEAT +226.8%
2026-04-26 (Q1 2026)
$0.05
Est. $0.09
MISS -45.5%
2026-01-26 (Q4 2025)
$0.06
Est. $0.09
MISS -34.6%
2025-10-26 (Q3 2025)
$-0.07
Est. $0.09
MISS -176.3%
Valuation Measures & Ratios
Enterprise Value4$1.41B
Forward P/E530.10
PEG Ratio6—
Price / Sales (TTM1)13.36
Price / Book721.29
EV4 / Revenue13.37
EV4 / EBITDA67.73
Profit Margin12.02%
Operating Margin15.44%
Return on Equity (ROE8)40.13%
Return on Assets (ROA9)12.37%
Avg Volume (3M)559,100
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $1.20B | $767.1M | $598.9M | $367.8M | $338.6M |
| P/E | 139.00 | -169.33 | -109.75 | -55.98 | -70.59 |
| Price/Sales | 11.61 | 9.25 | 8.68 | 6.61 | 7.58 |
| Price/Book | 25.72 | 25.05 | 25.90 | 15.35 | 13.85 |
| EV/Revenue | 11.53 | 9.24 | 8.54 | 6.65 | 7.19 |
| ROE | 18.50% | -14.80% | -23.60% | -27.42% | -19.62% |
| ROA | 7.44% | -4.64% | -5.22% | -6.46% | -5.71% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short1,834,090
Change from Prior Settlement+18.87%
% of Float—
Days to Cover (Short Ratio)2.94
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 98.6% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is 12.0%. Finnhub fundamentals ↗
- Trailing 52-week price return is +172.8%. Finnhub market metrics ↗
Potential concerns
- Trailing P/E is 111.2, a high price relative to reported earnings. Finnhub fundamentals ↗
- Latest SEC filing is Form 8-K, filed 2026-10-14; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on ETON
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $37.6M | $24.3M | $22.5M | $18.9M | $17.3M | $10.3M | $9.1M | $8.0M |
| Gross profit | $25.4M | $14.7M | $7.9M | $11.9M | $9.9M | $6.3M | $5.6M | $5.0M |
| Operating income | $12.8M | $2.4M | -$1.4M | -$1.5M | -$470.0K | $509.0K | -$2.9M | -$800.0K |
| Net income | $11.6M | $1.6M | -$1.9M | -$2.6M | -$1.6M | $627.0K | -$3.0M | -$811.0K |
| EPS (diluted) | $0.35 | $0.05 | $-0.07 | $-0.10 | $-0.06 | $0.02 | $-0.12 | $-0.03 |
| EPS (basic) | $0.42 | $0.06 | $-0.07 | $-0.10 | $-0.06 | $0.02 | $-0.12 | $-0.03 |
| Operating margin | $34 | $10 | -$6 | -$8 | -$3 | $5 | -$32 | -$10 |
| Net margin | $31 | $6 | -$9 | -$14 | -$9 | $6 | -$34 | -$10 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $115.8M | $97.7M | $92.1M | $104.5M | $101.7M | $84.0M | $76.1M | $35.8M |
| Total liabilities | $69.2M | $67.1M | $66.0M | $81.4M | $77.7M | $59.6M | $51.7M | $19.9M |
| Stockholders' equity | $46.6M | $30.6M | $26.2M | $23.1M | $24.0M | $24.4M | $24.4M | $16.0M |
| Total current assets | $68.6M | $53.2M | $60.6M | $72.0M | $68.4M | $50.0M | $41.0M | $29.7M |
| Total current liabilities | $45.1M | $44.2M | $38.5M | $44.2M | $38.6M | $25.4M | $19.9M | $19.7M |
| Cash & equivalents | $26.8M | $19.7M | $25.9M | $37.1M | $25.4M | $17.4M | $14.9M | $20.3M |
| Accounts receivable | $24.9M | $13.4M | $11.8M | $13.1M | $14.5M | $16.4M | $5.4M | $5.6M |
| Inventory | $10.1M | $14.5M | $15.4M | $16.9M | $23.8M | $13.6M | $15.2M | $1.9M |
| Property, plant & equipment | $352.0K | $372.0K | $326.0K | $294.0K | $18.0K | $22.0K | $34.0K | $33.0K |
| Intangible assets | $45.7M | $43.7M | $30.9M | $31.9M | $32.9M | $33.9M | $34.9M | $5.9M |
| Other non-current assets | $64.0K | $54.0K | $19.0K | $19.0K | $12.0K | $12.0K | $12.0K | $12.0K |
| Accounts payable | $14.4M | $13.5M | $11.0M | $14.3M | $12.1M | $4.9M | $4.2M | $2.7M |
| Accrued liabilities | $10.9M | $7.7M | $9.4M | $9.1M | $7.5M | $7.5M | $8.9M | — |
| Short-term debt | — | — | $8.8M | — | — | — | $0 | $4.1M |
| Long-term debt | $19.1M | $18.9M | $21.8M | $27.6M | $27.4M | — | $29.8M | — |
| Other non-current liabilities | $3.9M | $3.5M | $5.2M | $3.9M | $4.3M | $4.2M | $1.8M | — |
| Common stock & paid-in capital | $28.0K | $27.0K | $27.0K | $27.0K | $27.0K | $27.0K | $27.0K | $26.0K |
| Retained earnings | -$99.4M | -$110.9M | -$112.5M | -$114.0M | -$112.0M | -$109.5M | -$107.9M | -$107.3M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $7.3M | $7.4M | -$11.6M | $12.0M | $8.0M | $2.1M | -$765.0K | $3.0M |
| Investing cash flow | $5.0K | -$15.1M | -$49.0K | -$284.0K | $0 | $0 | -$38.1M | $0 |
| Financing cash flow | -$76.0K | $1.4M | $421.0K | $0 | $0 | $394.0K | $33.6M | -$385.0K |
| Free cash flow | $7.3M | $7.3M | -$11.6M | $11.7M | $8.0M | $2.1M | -$777.0K | $3.0M |
| Capital expenditures | -$5.0K | $75.0K | $49.0K | $284.0K | $0 | $0 | $12.0K | $0 |
| Depreciation & amortization | — | — | — | — | — | — | — | — |
| Share-based compensation | $1.5M | $1.5M | $1.1M | $1.1M | $2.1M | $1.2M | $782.0K | $722.0K |
| Change in accounts receivable | $11.5M | $1.7M | -$1.3M | -$1.4M | -$1.9M | $11.0M | $939.0K | $717.0K |
| Change in inventory | -$3.3M | -$1.4M | $581.0K | -$5.7M | $11.4M | -$358.0K | $812.0K | -$130.0K |
| Change in accounts payable | $921.0K | $2.5M | -$3.3M | $2.1M | $7.3M | $705.0K | $1.5M | $552.0K |
| Debt issued | — | — | $0 | — | — | — | $25.3M | — |
| Debt repaid | — | — | $0 | $0 | $0 | $0 | $0 | $385.0K |
| Tax withholding on stock comp | — | — | $0 | — | — | — | $0 | $0 |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $80.0M | $39.0M | $31.6M | $21.3M | $21.8M |
| Gross profit | $42.7M | $23.4M | $21.1M | $14.3M | $19.0M |
| Operating income | -$844.0K | -$2.6M | -$1.2M | -$8.3M | -$1.5M |
| Net income | -$4.6M | -$3.8M | -$936.0K | -$9.0M | -$2.0M |
| EPS (basic) | $-0.17 | $-0.15 | $-0.04 | $-0.36 | $-0.08 |
| Operating margin | -$1 | -$7 | -$4 | -$39 | -$7 |
| Net margin | -$6 | -$10 | -$3 | -$42 | -$9 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $92.1M | $76.1M | $31.7M | $25.0M | $27.5M |
| Total liabilities | $66.0M | $51.7M | $16.3M | $12.0M | $9.8M |
| Stockholders' equity | $26.2M | $24.4M | $15.5M | $13.1M | $17.6M |
| Total current assets | $60.6M | $41.0M | $26.8M | $20.0M | $23.6M |
| Total current liabilities | $38.5M | $19.9M | $16.2M | $6.5M | $4.6M |
| Cash & equivalents | $25.9M | $14.9M | $21.4M | $16.3M | $14.4M |
| Accounts receivable | $11.8M | $5.4M | $3.4M | $1.9M | $5.5M |
| Inventory | $15.4M | $15.2M | $911.0K | $557.0K | $550.0K |
| Property, plant & equipment | $326.0K | $34.0K | $58.0K | $72.0K | $115.0K |
| Intangible assets | $30.9M | $34.9M | $4.7M | $4.8M | $3.6M |
| Other non-current assets | $19.0K | $12.0K | $12.0K | $12.0K | $21.0K |
| Accounts payable | $11.0M | $4.2M | $1.8M | $1.8M | $1.8M |
| Accrued liabilities | $9.4M | $8.9M | $5.4M | $3.7M | $1.4M |
| Short-term debt | $8.8M | $0 | $5.4M | $1.0M | $1.4M |
| Long-term debt | $21.8M | $29.8M | — | — | — |
| Other non-current liabilities | $5.2M | $1.8M | $0 | — | — |
| Common stock & paid-in capital | $27.0K | $27.0K | $26.0K | $25.0K | $25.0K |
| Retained earnings | -$112.5M | -$107.9M | -$104.1M | -$103.1M | -$94.1M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $10.5M | $969.0K | $6.8M | $4.8M | -$4.7M |
| Investing cash flow | -$333.0K | -$40.0M | -$775.0K | -$2.8M | -$2.6M |
| Financing cash flow | $815.0K | $32.6M | -$957.0K | -$134.0K | $391.0K |
| Free cash flow | $10.2M | $943.0K | $6.8M | $4.8M | -$4.7M |
| Capital expenditures | $333.0K | $26.0K | $0 | $38.0K | $9.0K |
| Depreciation & amortization | — | — | — | $66.0K | $155.0K |
| Share-based compensation | $5.5M | $3.2M | $3.1M | $4.2M | $3.4M |
| Change in accounts receivable | $6.4M | $3.1M | $1.6M | -$3.6M | $5.4M |
| Change in inventory | $5.9M | $1.8M | $369.0K | $7.0K | -$692.0K |
| Change in accounts payable | $6.8M | $2.3M | $53.0K | -$8.0K | -$570.0K |
| Debt issued | $0 | $25.3M | $0 | $0 | — |
| Debt repaid | $0 | $1.2M | $1.2M | $385.0K | — |
| Tax withholding on stock comp | $0 | $0 | $180.0K | $0 | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding ETON as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-02-03 to 2026-10-06
Recent transactions
- Insiders have net sold 604,166 shares over the last 182 days, across 0 purchases and 24 sales.
- Most recent: Krempa David (Chief Business Officer) — Open market sale of 4,166 shares on 2026-10-06.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)604,166 sh(24 txns)
Net Shares-604,166
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Krempa David | Chief Business Officer | Open market sale | 2026-10-06 | 4,166 |
| MAIER PAUL V | Director | Option exercise | 2026-08-28 | 50,000 |
| BRYNJELSEN SEAN | President & CEO | Open market sale | 2026-08-20 | 47,307 |
| Opaleye Management Inc. | 10% owner | Open market sale | 2026-07-14 | 15,000 |
| Adams Jennifer McKie | Director | Option exercise | 2026-06-17 | 50,000 |
| RIEDEL NORBERT G | Director | Option exercise | 2026-04-21 | 12,500 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-06 | Krempa David | Chief Business Officer | Open market sale | 4,166 | $55.07 |
| 2026-10-02 | Krempa David | Chief Business Officer | Option exercise | 10,522 | — |
| 2026-08-28 | MAIER PAUL V | Director | Option exercise | 50,000 | $3.78 |
| 2026-08-28 | MAIER PAUL V | Director | Open market sale | 36,387 | $58.64 |
| 2026-08-28 | MAIER PAUL V | Director | Open market sale | 13,485 | $60.21 |
| 2026-08-28 | MAIER PAUL V | Director | Open market sale | 128 | $61.77 |
| 2026-08-24 | Krempa David | Chief Business Officer | Option exercise | 25,000 | $7.31 |
| 2026-08-24 | Krempa David | Chief Business Officer | Open market sale | 25,000 | $65.07 |
| 2026-08-20 | BRYNJELSEN SEAN | President & CEO | Open market sale | 47,307 | $60.17 |
| 2026-08-20 | BRYNJELSEN SEAN | President & CEO | Open market sale | 36,373 | $61.11 |
| 2026-08-20 | BRYNJELSEN SEAN | President & CEO | Open market sale | 7,342 | $62.12 |
| 2026-08-19 | BRYNJELSEN SEAN | President & CEO | Open market sale | 8,978 | $62.65 |
| 2026-07-14 | Opaleye Management Inc. | 10% owner | Open market sale | 15,000 | $37.54 |
| 2026-07-14 | Opaleye Management Inc. | 10% owner | Open market sale | 13,315 | $37.54 |
| 2026-07-14 | BRYNJELSEN SEAN | President & CEO | Option exercise | 200,000 | $1.37 |
| 2026-07-12 | BRYNJELSEN SEAN | President & CEO | Option exercise | 27,500 | — |
| 2026-07-12 | Krempa David | Chief Business Officer | Option exercise | 10,000 | — |
| 2026-07-07 | Opaleye Management Inc. | 10% owner | Open market sale | 20,000 | $38.37 |
| 2026-07-07 | Opaleye Management Inc. | 10% owner | Open market sale | 6,685 | $38.37 |
| 2026-07-06 | Opaleye Management Inc. | 10% owner | Open market sale | 10,000 | $38.00 |
| 2026-07-02 | Opaleye Management Inc. | 10% owner | Open market sale | 65,000 | $37.39 |
| 2026-07-02 | Opaleye Management Inc. | 10% owner | Open market sale | 25,000 | $37.39 |
| 2026-06-17 | Adams Jennifer McKie | Director | Option exercise | 50,000 | $3.78 |
| 2026-06-17 | Adams Jennifer McKie | Director | Open market sale | 50,000 | $32.48 |
| 2026-05-28 | BRYNJELSEN SEAN | President & CEO | Open market sale | 119,852 | $31.88 |
| 2026-05-28 | BRYNJELSEN SEAN | President & CEO | Open market sale | 148 | $32.67 |
| 2026-05-27 | Krempa David | Chief Business Officer | Option exercise | 12,476 | $1.37 |
| 2026-05-27 | Krempa David | Chief Business Officer | Option exercise | 7,203 | $3.58 |
| 2026-05-27 | Krempa David | Chief Business Officer | Open market sale | 19,679 | $31.47 |
| 2026-05-26 | Krempa David | Chief Business Officer | Option exercise | 25,000 | $1.38 |
| 2026-05-26 | Krempa David | Chief Business Officer | Option exercise | 12,524 | $1.37 |
| 2026-05-26 | Krempa David | Chief Business Officer | Open market sale | 37,524 | $31.49 |
| 2026-05-22 | Krempa David | Chief Business Officer | Option exercise | 30,591 | $3.58 |
| 2026-05-22 | Krempa David | Chief Business Officer | Open market sale | 32,963 | $33.22 |
| 2026-05-22 | Krempa David | Chief Business Officer | Open market sale | 9,315 | $33.88 |
| 2026-05-22 | Krempa David | Chief Business Officer | Open market sale | 519 | $35.00 |
| 2026-04-21 | RIEDEL NORBERT G | Director | Option exercise | 12,500 | $7.31 |
| 2026-04-21 | RIEDEL NORBERT G | Director | Option exercise | 19,655 | $8.61 |
| 2026-02-03 | RIEDEL NORBERT G | Director | In-the-money option exercise | 30,000 | $4.42 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 03:43 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-14 | 8-K | 2026-10-14 | View on SEC.gov → |
| 2026-10-06 | 4 | 2026-10-06 | View on SEC.gov → |
| 2026-09-28 | 8-K | 2026-09-28 | View on SEC.gov → |
| 2026-08-28 | 4 | 2026-08-28 | View on SEC.gov → |
| 2026-08-24 | 4 | 2026-08-24 | View on SEC.gov → |
| 2026-08-20 | 4 | 2026-08-19 | View on SEC.gov → |
| 2026-08-13 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-13 | 8-K | 2026-08-13 | View on SEC.gov → |
| 2026-08-05 | 8-K | 2026-07-31 | View on SEC.gov → |
| 2026-08-04 | 4 | 2026-07-31 | View on SEC.gov → |
| 2026-08-04 | 4 | 2026-07-31 | View on SEC.gov → |
| 2026-08-04 | 4 | 2026-07-31 | View on SEC.gov → |
Recent news
Headlines about ETON (Eton Pharmaceuticals, Inc.). Links open the publisher — we don’t host full articles.
-
Eton Pharmaceuticals, Inc. (ETON) Stock Price Prediction for 2026, 2030-2040
Traders Union · 2026-10-21 -
Eton Properties expands offerings with new CCF Community Hub
BusinessMirror · 2026-10-20 -
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Stock Has Consensus Target Price of $71.50 According to Brokerages
MarketBeat · 2026-10-20 -
Eton Pharmaceuticals (ETON) Stock May Be Trading At A Premium Following Its Huge Three Year Run
Simply Wall Street · 2026-10-20 -
Eton Pharmaceuticals (NASDAQ:ETON) Given Buy Rating at HC Wainwright
MarketBeat · 2026-10-19 -
Eton Pharmaceuticals (ETON) Draws Fresh Valuation Focus, Is It Still A Bargain?
Simply Wall Street · 2026-10-18 -
'Beaks,' 'divs,' and 'halves': The exclusive Eton language Prince George had to learn
Yahoo Creators · 2026-10-17 -
ETON270521C00045000 interactive stock chart | ETON May 2027 45.000 call stock
Yahoo Finance Australia · 2026-10-17
No headlines in this category right now — try “All”.